Dr. Emma Lawson is a leading Breast Cancer Specialist at the Metropolitan Cancer Institute. With over 15 years of experience in breast cancer treatment and research, Dr. Lawson has a deep expertise in clinical trials, personalized medicine, and patient care. She is a pivotal contributor to national guidelines on breast cancer management and serves on several advisory boards, including the American Society of Clinical Oncology (ASCO).
Dr. Lawson’s dedication to integrating cutting-edge research into clinical practice ensures that her patients receive the most advanced care available. Her work has been widely published in top medical journals, and she is a sought-after speaker at international oncology conferences. In addition to her clinical and research responsibilities, Dr. Lawson is committed to mentoring the next generation of oncologists, fostering a collaborative and innovative environment at the institute. Her contributions to the field have been recognized with several prestigious awards, underscoring her impact on breast cancer treatment and patient outcomes.
Dr. Michael Thompson is a renowned medical oncologist specializing in breast cancer. He is deeply committed to providing patient-centered care, tailoring individual treatment plans through targeted therapies, immunotherapy, and chemotherapy. Dr. Thompson’s passion for treating breast cancer stems from his dedication to improving patient outcomes and quality of life, ensuring each patient receives the best possible care. In addition to his clinical expertise, Dr. Thompson is an accomplished researcher with extensive experience in designing and implementing innovative clinical trials. His work has been instrumental in bringing new treatment options to the forefront of breast cancer care, making significant advancements in the field.
Dr. Thompson earned his Bachelor of Science in Biochemistry from the University of California, Berkeley, and received his medical degree from Stanford University School of Medicine. He completed his residency in internal medicine at Massachusetts General Hospital, affiliated with Harvard Medical School, where he also served as Chief Resident. Following this, he completed a fellowship in medical oncology at the Dana-Farber Cancer Institute, where he was honored with the Excellence in Research Award. Dr. Thompson continues to manage complex breast cancer cases through a multidisciplinary approach and collaborates with experts across various fields to provide comprehensive care.
Dr. Olivia Harper is a leading oncologist specializing in breast and gynecologic cancers. She focuses on developing and implementing innovative therapeutic approaches for women’s malignancies. Dr. Harper’s expertise includes targeted biologic therapies and personalized treatment plans that aim to improve patient outcomes and quality of life.
Dr. Harper earned her medical degree from Yale School of Medicine and completed her residency in internal medicine at Johns Hopkins Hospital. She then pursued a fellowship in medical oncology at the Memorial Sloan Kettering Cancer Center. Her research interests include genetic counseling and the development of new strategies for cancer screening and prevention. Dr. Harper is an active member of the Gynecologic Oncology Group and frequently lectures on national and international platforms.
Dr. Harper’s commitment to advancing breast cancer treatment is reflected in her leadership of numerous clinical trials and her collaboration with multidisciplinary teams to provide comprehensive care for her patients.